-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

653. Multiple Myeloma: Clinical and Epidemiological: Poster III

Symposia: Multiple Myeloma: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Muhammad Kashif, PhD1*, Niki Throumpari2*, Katarina Uttervall2,3*, Kristin Roseth Aass4*, Therese Standal, PhD4*, Kristine Misund, PhD4*, Hareth Nahi, MD2,5*, Robin Mjelle, PhD4*, Evren Alici, MD2 and Johan Lund, MD, PhD2,3*

1Department of Medicine, Karolinska Institutet, Huddinge, Sweden
2Department of Medicine, Karolinska Institutet, Stockholm, Sweden
3Hematology Medical Unit, Karolinska University Hospital, Stockholm, Sweden
4Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway
5Department of Medicine, Södersjukhuset, Stockholm, Sweden

Binod Dhakal, MBBS1, Michael Slade, MD, MS2, Ravi Narra, MD3*, Mostafa E. Mohamed4*, Othman S. Akhtar, MD1*, Hima Bansal, PhD5*, Maria Jose Acevedo-Calado, PhD5*, Oren Pasvolsky, MD6*, Mahmoud R. Gaballa, MD5, Melody R. Becnel, MD7, Donna M. Weber, MD5, Krina K. Patel, MD, MSc8, Sheeba K. Thomas, MD7, J Christine Ye, MD9*, Frank Kuhr10*, Bamboo Dong11*, Shemeeakah Powell10*, Thai Bui10*, Meera Mohan, MD12, Marcelo C. Pasquini, MD, MS13, Anita D'Souza, MD, MS1*, Halyna Knysh10*, Robert Z. Orlowski, MD, PhD5, Maher Albitar, MD14* and Hans C. Lee, MD15

1Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2Division of Oncology, Washington University School of Medicine, St. Louis, MO
3BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma & Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
10Menarini Silicon Biosystems, Bryn Athyn
11Menarini Silicon Biosystems, Huntingdon Valley, PA
12Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
13Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
14Genomic Testing Cooperative, Lake Forest, CA
15Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX

Johannes Waldschmidt, MD1, Maximilian Merz, MD2, Judith S. Hecker, MD3*, Franz Reinhard4*, Benjamin GT Shibru2*, Marion Hoegner, MD5*, Anna Gebauer4*, David Fandrei, MSc2*, Manja Meggendorfer, PhD6, Marietta Truger7*, Johannes Jung8*, Daniel Teschner, MD1*, Max S. Topp1*, Anna Purcarea, MD9*, Vladan Vucinic, MD10*, Martin K. Kortüm4*, Torsten Haferlach, MD7, Florian Bassermann, MD11*, Uwe Platzbecker, MD12, Hermann Einsele, MD4, Claudia Haferlach, MD7, Klaus H Metzeler, MD2, Katharina S. S. Götze, MD3 and Leo Rasche, MD13*

1Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
2Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
3Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
4Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
5Department of Medicine III, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
6MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
7MLL Munich Leukemia Laboratory, Munich, Germany
8Technical University of Munich (TUM), School of Medicine and Health, Munchen, DEU
9Department of Medicine III and Center for Translational Cancer Research, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
10Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
11Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
12Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany
13Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Mohamed Bikhet, MBBCh1*, Halimat Olaniyan, MD1, Wen Niu, MS2*, Marwan Tayeh, PhD3*, Francesco Vetrini, PhD2,4* and Nichole LePage, MD1*

1Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
2Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN
3Indiana University School of Medicine, Undiagnosed Rare Disease Clinic, Indianapolis, IN
4Indiana University School of Medicine, Undiagnosed Rare Disease Clinic, Ind, IN

Steven Shih, MBBS1, Harjot Vohra, MD, CCRP, MLT1*, Anup Joseph Devasia, MD, DM1*, Sahar Khan, FRCPath, MB BCh2*, Eshetu Atenafu, M.Sc, P. Stat3*, Donna Reece, MD1, Suzanne Trudel, MD, MSc1, A. Keith Stewart, MBChB1, Sita D. Bhella, MD1, Vishal Kukreti, MD, MSc4, Chloe Yang, MD1*, Rodger E. Tiedemann1, Anca Prica, MD1, Eugene Leung, CCPA, BScPA, RT(T)1* and Christine I Chen, MHPE, MD5

1Princess Margaret Cancer Centre, Toronto, ON, Canada
2Windsor Regional Cancer Centre, Windsor, ON, Canada
3Biostatistics, University Health Network, Toronto, Canada
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Leah Grossman1,2*, Adolfo Aleman, Jr.1,3*, Morgan van Kesteren4,5*, Sidorela Reci, BS1,3*, Charles Gleason4,5*, Kseniya Serebryakova1,3*, Katerina Kappes, BSc1,3*, Hayley Jackson1,3*, Jessica Nardulli4,5*, Hyun Min Kang4,5*, Jacob Mischka4,5*, Komal Srivastava4,5*, Lubbertus CF Mulder4,5*, Sundar Jagannath, MD1, Florian Krammer, PhD4,5*, Viviana Simon, MD, PhD4,5,6,7,8* and Samir Parekh, MD1,3

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY
3Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
4Center for Vaccine Research and Pandemic Preparedness, New York, NY
5Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
6The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY
7Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
8Department of Pathology, Molecular and Cell based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Ziad Abuhelwa, MD, MPH1,2, Fnu Amisha, MD2,3, Wenyi Fan, MSPH1*, Gabriel De Avila1*, Doris K. Hansen, MD4, Ariel F. Grajales-Cruz, MD1, Brandon Blue1, Omar Castaneda, MD4, Hien Liu, MD5, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP4, Taiga Nishihori, MD5, Frederick Locke, MD5, Kenneth H. Shain, MD, PhD6, Rachid Baz, MD5 and Melissa Alsina, MD5

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Morsani College of Medicine, University of South Florida, Tampa, FL
3Department of Hematology and Oncology, USF Morsani/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Moffitt Cancer Center, Tampa, FL
6H. Lee Moffitt Cancer Center, Tampa, FL

Lingling Shu, Ph.D1*, Ziang Zhu1*, Yang Li2*, Hanying Huang3*, Xiaoqin Chen, MD, PhD4*, Zhongjun Xia, MD5* and Yang Liang6

1Department of Hematological Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2Sun Yat-Sen University Cancer Center, Guangzhou, CHN
3Department of Hematologic Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
4Department of Hematological Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China
5Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
6Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Noemi Puig, PhD1, Panagiotis Malandrakis, MD2*, Cristina Agullo3*, Sergio Castro4*, Teresa Contreras3*, Veronica Gonzalez-Calle, MD, PhD5*, Beatriz Rey-Búa6*, Borja Puertas Martínez7*, Evangelos Terpos, MD, PhD2, Meletios A. Dimopoulos2,8,9,10,11,12,13,14, Maria- Victoria Mateos7,15,16,17 and Efstathios Kastritis, MD2,12,18*

1Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain, Salamanca, Spain
2Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
3Biochemistry Department, University Hospital of Salamanca, Salamanca, ESP
4Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
5University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Salamanca, ESP
6Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain
7University Hospital of Salamanca, Salamanca, Spain
8Princess Margaret Hospital, Toronto, ON, Canada
9Alexandra General Hospital, Athens, Greece
10General Hospital of Athens-Alexandra, Llisia, Greece
11University of Athens School of Medicine, Athens, Greece
12National and Kapodistrian University of Athens, Athens, Greece
13Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
14National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece
15Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca., Salamanca, Spain
16University of Salamanca, Department of Medicine, Salamanca, Spain
17Salamanca/Instituto de Investigacio´ n Biome´ dica de Salamanca/Centre for Cancer Research Institute of Cancer Molecular and Cellular Biology, Salamanca, Spain
18Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece

Nadine Abdallah, MD1, Matthew Rees1*, Supriya Gupta, MD2, Mohammed Elhaj1*, Radhika Bansal, MBBS3,4*, Terri Menser5*, Gavin Schaeferle1*, Joselle Cook, MBBS6, Taxiarchis Kourelis, MD2, Rahma M Warsame, MD2, Wilson I. Gonsalves, MD7, Prashant Kapoor, MD1, Francis Buadi, MD2, Suzanne R Hayman, MD2, David Dingli, MD, PhD2, Morie A. Gertz, MD2, Yi Lin, MD, PhD2 and Shaji Kumar, MD2

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Bismarck, ND
4Internal Medicine, Zucker School of Medicine at Hofstra/Northwell at Lenox Hill, New York, NY
5Health Care Delivery Research, Mayo Clinic, Rochester, MN
6Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
7Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN

Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc*, Charalampos Filippatos*, Anastasios Ntanasis-Stathopoulos, MD*, Panagiotis Malandrakis, MD*, Efstathios Kastritis, MD, PhD*, Meletios A. Dimopoulos, MD, Evangelos Terpos, MD, PhD and Maria Gavriatopoulou*

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Alexandra Dreyfuss, MD, MSTR1*, Beatrice Fregonese, MPH1*, Saad Z. Usmani, MD2, Sham Mailankody, MD, MBBS2, Brandon S. Imber, MD, MA1 and Joachim Yahalom, MD1

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Hee Jeong Cho1,2*, Myung-Won Lee, MD3, Yunji Lee, M.D.4*, Jungmin Lee, PhD5*, Jae Hoon Lee6*, Hyun-Seok Uhm7*, Jong Heon Jung7*, Ho-Young Yhim, MD8*, Dok Hyun Yoon, MD, PhD9, Hyungwoo Cho, MD10*, Sung-Soo Yoon, M.D., Ph.D.11, Ja Min Byun, MD, PhD11, Young Rok Do, MD, PhD12, Hyo Jung Kim, MD, PhD13*, Ji Hyun Lee, MD, PhD14, Sung-Nam Lim, MD15*, Hye Jin Kang16*, Ho Sup Lee, MD, PhD17*, Yundeok Kim, MD18*, Hee jeong Lee19*, Sang Min Lee, MD20*, Joon Ho Moon, MD21 and Kihyun Kim, MD, PhD22

1Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea, Republic of (South)
2Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
3Department of Internal Medicine, College of Medicine, Chungnam National University, Sejong, Korea, Republic of (South)
4Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
5Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, KOR
6Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
7National Cancer Center, Goyang, Korea, Republic of (South)
8Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea, Republic of (South)
9Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
10Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
11Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
12Department of Hemato-Oncology, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
13Hallym University Sacred Heart Hospital, Anyang-Si, Korea, Republic of (South)
14Dong-A University College of Medicine, Busan, South Korea
15Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
16Korea Cancer Center Hospital, Seoul, KOR
17Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
18Wonju Severance Christian Hospital, Wonju, KOR
19Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Korea, Republic of (South)
20Inje University Busan Paik Hospital, Busangingu, Busan, KOR
21Department of Hematology, Kyungpook National Univ. Hospital, Daegu, Korea, Republic of (South)
22Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Enrica Antonia Martino, MD1*, Daniele Derudas2*, Elena Rossi, MD3*, Sofia Terlizzi4*, Giovanni Reddiconto5*, Paola Stefanoni6*, Jacopo Micozzi, MD7*, Silvia Mangiacavalli, MD8*, Elena Zamagni, MD9*, Massimo Offidani, MD 10*, Anna Furlan, MD11*, Gabriele Buda Sr.12, Flavia Lotti, MD13*, Carmine Liberatore14*, Antonio Lazzaro15*, Roberta Della Pepa, MD16*, Giuseppe Bertuglia17*, Emiliano Barbieri18*, Concetta Conticello, MD19*, Claudio De Magistris20*, Lorenzo De Paoli21*, Velia Bongarzoni22*, Anna Maria Cafro, MD23*, Anna Mele, MD24*, Pietro Benvenuti25*, Claudio Cerchione, MD26, Cirino Botta, MD, PhD27*, Elisabetta Antonioli28*, Nicola Sgherza29*, Sara Aquino, MD, PhD30*, Giuseppe Mele31*, Gregorio Barila32*, Salvatore Palmieri33*, Ombretta Annibali, MD34*, Rosario Bianco, MD35*, Massimiliano Arangio Febbo, MD36*, Gloria Margiotta Casaluci, MD37*, Angela Rago38*, Raffaele Fontana, MD39*, Francesca Farina40*, Ernesto Vigna, MD41*, Antonella Bruzzese42*, Catello Califano, MD43*, Angela Amendola44*, Daniela Roccotelli, MD45*, Alessandra Lombardo, MD46*, Annalisa Citro47*, Giuseppina Uccello48*, Renato Zambello49*, Alessandro Maggi, MD50*, Santo Neri51*, Michele Monachesi52*, Alessandro Gozzetti53*, Vittorio Montefusco, MD54*, Marino Brunori55*, Nicola Di Renzo56*, Marta Coscia, MD, PhD57*, Valerio De Stefano, MD3*, Antonino Neri, MD58*, Francesco Di Raimondo, MD, Prof59, Fortunato Morabito60*, Pellegrino Musto61,62* and Massimo Gentile, MD63,64*

1Department of Onco-Hematology, Hematology Unit AO of Cosenza, Cosenza, Italy
2Department of Hematology, Struttura Complessa di Ematologia e Centro Trapianto Cellule Staminali Emopoieti, Cagliari, Italy
3Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Roma, Italy
4Department of Hematology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy
5Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, ITA
6Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
7Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
8Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
10Clinica di Ematologia Ospedali Riuniti Ancona, Ancona, Italy
11Divisione di Ematologia, Ospedale Cà Foncello di Treviso-ASL 2, Treviso, Italy
12university of pisa, Pisa, PI, Italy
13Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant’Andrea delle Fratte, Perugia, Italy
14Hematology Unit, Department of Oncology and Hematology,, Ospedale Santo Spirito, Pescara, ITA
15Division of Hematology and Bone Marrow Transplant Center, Hospital Guglielmo da Saliceto, PIACENZA PC, ITA
16Department of Clinical Medicine and Surgery, AOU Federico II, Naples, Italy
17Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
18Hematology Unit, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
19AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, Catania, ITA
20Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, milan, Italy
21Division of Hematology, Ospedale Sant’Andrea, Vercelli, Italy
22Department of Hematology, San Giovanni-Addolorata Hospital, ROMA, ITA
23Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
24Hematology Unit, Azienda C. Panico, Tricase, Italy
25Department of Medicine and Surgery, University of Insubria and Department of Oncology, ASST Sette Laghi, Ospedale di Circolo, Varese, ITA
26Hematology Unit, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola (FC), Italy
27University of Palermo, Palermo, ITA
28Careggi Hospital and University of Florence, Firenze, Italy
29Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy
30Ematologia e Terapie cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy
31Haematology and Stem Cell Transplant Unit, Ospedale Antonio Perrino, Brindisi, AL, Italy
32Hematology Unit, Ospedale San Bortolo, Vicenza, Italy
33Ospedale A. Cardarelli, Napoli, Italy, Napoli, Italy
34Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
35UOC Ematologia, AORN Sant’Anna e San Sebastiano di Caserta, Caserta, ITA
36Onco Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
37Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
38UOSD Ematologia, ASL Roma 1, Roma, Italy
39Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
40Hematology and BMT unit, IRCCS Ospedale San Raffaele, Milano, Italy
41U.O. Di Ematologia, Ospedale L'Annunziata, Cosenza, ITA
42Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, COSENZA, Italy
43EMATOLOGIA, ASL SALERNO, PRESIDIO OSPEDALIERO TORTORA PAGANI, Pagani, ITA
44Ematologia, AOR San Carlo, Potenza, Potenza, ITA
45Department of Hematology and Bone Marrow Transplant, IRCSS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy
46S.C. di Oncoematologia, A.O. Santa Maria di Terni, Terni, Italy
47UOC Ematologia, Ospedale Civile di Legnano, Legnano, Italy
48Hematology Unit, Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi, Catania, Italy
49Department of Medicine, Hematology and Clinical Immunology section, Padua University School of Medicine, Padova, Italy
50Division of Hematology and Bone Marrow Transplant, Ospedale S.G. Moscati, Taranto, Italy
51Hematology Unit, Azienda Ospedaliera Papardo, Messina, IT-ME, ITA
52Institute of Hematology, Perugia University and IbiT Foundation, Perugia, Italy
53Division of Hematology, University of Siena, Siena, Italy
54Hematology, ASST Santi Paolo e Carlo, Milan, Italy
55Ematologia Ospedale Santa Croce Fano, Fano, Italy
56"Vito Fazzi" Hospital, Hematology and Stem Cell Transplant Unit, Lecce, Italy
57Hematology Division, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy
58Scientific Directorate, Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy
59Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Catania, Italy, Catania, Italy
60Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy
61Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
62Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine,and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Bari, Italy
63Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy, Cosenza, Italy
64Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy

Jing Li, MD1*, Yang Yang, MD1*, Chenqi Yu, MD1*, Yuxia Yang2* and Peng Liu, MD1,3

1Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
2Yikon Genomics, Suzhou, China
3Department of Hematology, Shanghai Geriatric Medical Center, Shanghai, China

Marina Hajiyianni1*, Christos Sachpekidis, MD2*, Annette Kopp-Schneider, PhD3*, Elias Karl Mai, MD1*, Sandra Sauer, MD1*, Ekaterina Menis, PhD1*, Michael Hundemer, MD4*, Niels Weinhold, PhD5, Jens Hillengass, MD, PhD6, Marc-Steffen Raab, MD1*, Antonia Dimitrakopoulou-Strauss, MD2* and Hartmut Goldschmidt, MD1

1Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
3Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
4Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
5Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
6Department of Medicine - Myeloma, Roswell Park, Buffalo, NY

Cindy Varga, MD, BSc1, Myra Robinson2*, Vikas Gupta3*, Craig C. Hofmeister, MD4, Ajay K. Nooka, MD, MPH5, Jonathan L. Kaufman, MD4, Madhav V. Dhodapkar, MD PhD4, Sagar Lonial, MD4*, Shanice Borden6*, Christopher Ferreri7, Barry Paul, MD, MS7, Shebli Atrash, MD, MS7, Manisha Bhutani, MD8, Peter M. Voorhees, MD9 and Nisha S. Joseph, MD4

1Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Matthews, NC
2Department of Biostatistics and Data Sciences, Levine Cancer Institute, Charlotte, NC
3Emory Winship Cancer Institute, Atlanta
4Winship Cancer Institute of Emory University, Atlanta, GA
5Winship Cancer Institute Suite 5010, Atlanta, GA
6Levine Cancer Institute, Atrium Health, Charlotte, NC
7Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
8Atrium Health Levin Cancer Institute, Charlotte, NC
9Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Chenya Zhao, MS1*, Loic Le Marchand2*, Lynne Wilkens2*, Howard Hu3*, Christopher Haiman3* and Wendy Cozen, DO, MPH4

1Department of Population and Health Sciences, University of Southern California, Alhambra, CA
2University of Hawai'i Cancer Center, University of Hawai'i, Honolulu, HI
3Department of Population and Health Sciences, University of Southern California, Los Angeles, CA
4Division of Hematology-Oncology, Department of Medicine, UCI, School of Medicine, Orange, CA

Saurabh Zanwar, MD, MBBS1, Dragan Jevremovic, M.D., Ph.D2*, Prashant Kapoor, MD2, Horatiu Olteanu, M.D., Ph.D.3, Francis Buadi, MD1, Pedro Horna, MD3, Wilson I. Gonsalves, MD4, Gregory Otteson5*, Suzanne R Hayman, MD6, Nadine Abdallah, MD2, Moritz Binder, MD1, Joselle Cook, MBBS6, Angela Dispenzieri, MD1, David Dingli, MD, PhD1, Morie A. Gertz, MD6, Taxiarchis Kourelis, MD1, Nelson Leung, MD7, Yi Lin, MD, PhD1, Eli Muchtar, MD1, Rahma M Warsame, MD1, Amie Fonder, PA-C, MS8*, Miriam Hobbs, APRN, CNP, DNP1*, Yi Lisa Hwa, APRN, DNP, CNP1, Michelle G. Rogers, CNP1*, Robert A. Kyle, MD1, Vincent Rajkumar, MD1* and Shaji Kumar, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematopathology, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
7Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
8Hematology, Mayo Clinic, Rochester, MN

Xiang Zhou, MD, BMBS1, Sarah Wiethe2*, Angelika Wolff2*, Max J Steinhardt3*, Nazia Afrin4*, Mara John5*, Christine Riedhammer, MD6*, Xianghui Xiao, MD7*, Umair Munawar8*, Julia Mersi, MD9*, Seungbin Han, MSc10*, Johannes Waldschmidt, MD3,11,12, Angela Riedel, PhD5*, Max S. Topp13*, Johannes Duell, MD14*, Hermann Einsele, MD3, K. Martin Kortüm, MD15* and Leo Rasche, MD16*

1University Hospital Wuerzburg, Wurzburg, Germany
2University Hospital Wurzburg, Wurzburg, Germany
3Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
4Mildred Scheel Early Career Center for Cancer Research, University Hospital Wuerzburg, Wuerzburg, Germany
5Mildred Scheel Early Career Center for Cancer Research, University Hospital Wurzburg, Wurzburg, Germany
6Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
7Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
8University Hospital of Wuerzburg, Wuerzburg, Germany
9Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
10University of Wurzburg, Wuerzburg, DEU
11Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
12Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Baden Wurttemberg, Germany
13University Hospital Wuerzburg, Wuerzburg, Germany
14University of Wurzburg, Wurzburg, Germany
15Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
16Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany

Rabia Iqbal1*, Ahmad Taimoor Bajwa2*, Aemen Shafqat Bazaz3*, Mrunanjali Gaddam, MD1*, Fiqe Khan4*, Nyan Linn Htet4*, Aqsa Mumtaz, MD, MBBS5* and Faiz Anwer, MD6

1Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY
2The Brooklyn Hospital Center, brooklyn, NY
3Rawalpindi Medical University, Rawalpindi, Pakistan
4The Brooklyn Hospital Center, Brooklyn
5Montefiore St. Luke's Cornwall, Newburgh, NY
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Ja Min Byun, MD, PhD1, Sung-Soo Park, MD, PhD2*, Suein Choi3*, Youngil Koh, MD, PhD1, Chang-Ki Min4* and Seunghoon Han5*

1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
2Division of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Department of Pharmacology, College of Medicine, The Catholic University of Kore, Seoul, KOR

Utkarsh Goel, MBBS1, Danai Dima, MD2,3, James A Davis, PharmD4*, Aliya Rashid, DO, MPH5, William Wesson, MD, MPH6, Shaun DeJarnette7*, Fauzia Ullah, MD8*, Evguenia Ouchveridze, MD7, Mariam Markouli, MD9*, Claire Yun Kyoung Ryu Tiger, MD10*, Louis Williams, MD8, Sandra Mazzoni, DO2*, Beth M. Faiman, PhD, CNP8, Craig Sauter, MD11*, Faiz Anwer, MD2, Shahzad Raza, MD2, Leyla O. Shune, MD7 and Jack Khouri, MD8

1Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3University of Washington, Seattle, WA
4Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
6School of Medicine, University of Kansas Medical Center, Kansas City, KS
7University of Kansas Medical Center, Kansas City, KS
8Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9Boston University Medical Center, Boston
10Rutgers Cancer Institute, New Brunswick, NJ
11Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Yuntong Liu1*, Lu-Gui Qiu, MD2 and Gang An3*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, UT, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Xiaozhe Li1* and Juan Li, PhD2

1The first affliated of sun yat-sen university, Guangzhou, China
2The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Jacob T Shreve, MD1, Michael D Howe2*, Emmanuel Contreras Guzman1*, Charalampos Charalampous1*, Wilson I. Gonsalves, MD1, Francis Buadi, MD1, Taxiarchis Kourelis, MD1, Suzanne R Hayman, MD1, Morie A. Gertz, MD1, Rafael Fonseca, MD1, S. Vincent Rajkumar, MD1*, Surendra Dasari, PhD3*, Matthew P. Thorpe4*, Stephen Broski4*, Shaji Kumar, MD1 and Moritz Binder, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Department of Radiology, Mayo Clinic, Rochester, MN

Cindy Varga, MD1*, Myra Robinson2*, James Davis, MD3*, Hamza Sloan Hashmi, MD4*, Thomas Martin, MD5, Anupama Deepa Kumar, MD6, Douglas W Sborov, MD7, Charlotte B Wagner, PharmD8*, Doris K. Hansen, MD9, Omar Castaneda, MD9, Leyla O. Shune, MD10, Shaun DeJarnette10*, Aimaz Afrough, MD11, Larry D Anderson Jr., MD, PhD12, Binod Dhakal, MBBS13, Kinaya Smith, MD14*, Megan M Herr, PhD15, Shambavi Richard, MD16, Alex Lieberman-Cribbin16*, Daniel W. Sherbenou, MD, PhD17, Peter A. Forsberg, MD18 and Peter M. Voorhees, MD19

1Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
2Department of Biostatistics and Data Sciences, Levine Cancer Institute, Charlotte, NC
3Department of Hematology-Oncology, The Medical University of South Carolina (MUSC), Charleston, SC
4Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
5Department of Hematology, University of California at San Francisco, San Francisco, CA
6University of California, San Francisco, San Francisco, CA
7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
8Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
9Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10University of Kansas Medical Center, Kansas City, KS
11Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
12Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
13Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
14Medical College of Wisconsin, Milwaukee, WI
15Roswell Park Comprehensive Cancer Center, Buffalo, NY
16Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
17Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
18University of Colorado School of Medicine, Aurora, CO
19Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Sharmilan Thanendrarajan, MD1, Phil Farmer2*, Clyde Bailey, BS1*, Carolina Schinke, MD1, Samer Al Hadidi, MD, MSc3, Maurizio Zangari, MD1, Stephanie Rogers, MNSc, APRN, AGPNP-BC1*, Anne Williams, APRN, MNSc, FNP-C1*, Fenghuang Zhan, MD1, John D Shaughnessy, Jr, PhD4*, Tanvi H. Patel, MD1*, Anup Kumar Trikannad, MD5, Asis Shrestha, MD1*, Syed Naqvi, MD2*, Hira Imad Cheema, MD1*, Trilok Shrivastava, MD1*, Manozna Karri, MD1*, Ramya Bachu, MD1* and Frits van Rhee, MD, PhD1

1Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
2Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
3University of Arkansas for Medical Sciences, Little Rock, AR
4Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical sciences, Little Rock, AR
5Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, LITTLE ROCK, AR

Johannes Waldschmidt, MD1, Mark Kidd, PhD2*, Sophia Danhof3*, Martin Schreder, MD4*, Ignat Drozdov2*, Cornelia Vogt1*, Hermann Einsele, MD3, Leo Rasche, MD5*, Abdel Halim2* and Martin K. Kortüm3*

1Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
2Wren Laboratories, Branford, CT
3Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
4First Department of Medicine, Klinik Ottakring, Vienna, Austria
5Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany

Maria Gavriatopoulou1*, Vassilis Koutoulidis2*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc1*, Panagiotis Malandrakis, MD1*, Maria Douka2*, Vasiliki Spiliopoulou, MD1*, Charalampos Filippatos1*, Despina Fotiou, MD1*, Magdalini Migkou, MD1*, Nikolaos Kanellias1*, Evangelos Eleutherakis-Papaiakovou, MD1*, Efstathios Kastritis, MD1*, Evangelos Terpos, MD, PhD1, Meletios A. Dimopoulos1 and Lia-Angela Moulopoulos2*

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
21st Department of Radiology, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece

Abiola Bolarinwa, MBBS, FMCPath1*, Saurabh Zanwar, MD, MBBS1, Nadine Abdallah, MD2, Sukriti Seth1*, Francis Buadi, MD1, Suzanne R Hayman, MD1, Morie A. Gertz, MD1, Angela Dispenzieri, MD1, Eli Muchtar, MD1, Prashant Kapoor, MD2, Wilson I. Gonsalves, MD3, Taxiarchis Kourelis, MD1, David Dingli, MD, PhD1, Rahma M Warsame, MD1, Nelson Leung, MD1, Joselle Cook, MBBS1, Moritz Binder, MD1, Yi Lin, MD, PhD1, Yi Lisa Hwa, APRN, DNP, CNP1, Michelle G. Rogers, CNP1*, Miriam Hobbs, APRN, CNP, DNP1*, Amie Fonder, PA-C, MS1*, Dragan Jevremovic, M.D., Ph.D4*, S. Vincent Rajkumar, MD1 and Shaji Kumar, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
4Division of Hematopathology, Mayo Clinic, Rochester, MN

Charles Pei1*, Lisa Blackburn2*, Nidhi Sharma, PhD3*, Naresh Bumma, MD4, Abdullah Mohammad Khan, MD, MBBS5, Srinivas Devarakonda, MD6, Elvira Umyarova, MD7, Don Benson, MD8, Ashley Rosko, MD9, Zeinab El Boghdadly, MD10* and Francesca Cottini, MD9

1The Ohio State University, College of Medicine, Columbus, OH
2The Ohio State University, College of Medicine, Columbus
3Division of Hematology, Ohio State University Medical Center, Columbus, OH
4The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
5Division of Hematology, The Ohio State University, Columbus, OH
6Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
7Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Ohio State University Medical Center, Columbus, OH
9The Ohio State University, Columbus, OH
10Division of Infectious Diseases, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH

Carlos Costa, MD1*, Adriana Isabel Roque, MD, BSc2,3*, João Santinha, PhD4*, Manuel Neves, MD5*, Ana Bela Sarmento-Ribeiro, MD, PhD2,6,7,8,9*, Rita Gerivaz, MD10*, Ana Luisa Tomé, MD11*, Helena Martins, MD12*, Joana Vieira, MD12*, Sofia Afonso, MD13,14*, Joana Santos, MD10*, Celina Afonso, MD15*, Ana Jorge, MD15*, José Freitas, MD16*, Inês Ramos, MD17*, Patrícia Sousa, MD13,18*, Paula César, MD18*, Teresa Garrido, MD18*, Dina Rochate, MD19*, Maria Pedro Silveira, MD20,21*, Fernanda Trigo Miranda, MD22,23*, Rui Bergantim, MD22,23,24,25*, Catarina Geraldes Santos, MD, PhD2,6,7,8,9* and Cristina Joao, MD, MSc, PhD5,26,27*

1Hematology Unit, Hospital CUF Tejo, Lisboa, Lisbon, Portugal
2Clinical Hematolology Unit, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal
3Institute of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
4Digital Surgery Lab, Champalimaud Foundation, Lisbon, Portugal
5Hemato-Oncology Unit, Champalimaud Foundation, Lisbon, Portugal
6University Clinics of Hematology and Oncology and Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
7Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
8Coimbra Institute for Clinical and Biomedical Research (iCBR)—Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
9Clinical Academic Center of Coimbra (CACC), University of Coimbra, Coimbra, Portugal
10Clinical Hematolology Unit, Hospital Santo António dos Capuchos, Unidade Local de Saúde São José, Lisbon, Portugal
11Clinical Hematolology Unit, Hospital Garcia da Orta, Unidade Local de Saúde de Almada-Seixal, Almada, Portugal
12Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria, Lisboa, Portugal
13Serviço de Hematologia Clínica, Hospital Pêro da Covilhã, Unidade Local de Saúde da Cova da Beira, Covilhã, Portugal
14Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
15Clinical Hematolology Unit, Hospital de São Francisco Xavier, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, Portugal
16Serviço de Hematologia, Hospital de Braga, Unidade Local de Saúde de Braga, Porto, Portugal
17Serviço Onco-Hematologia, Instituto Português Oncologia Porto, Porto, Portugal
18Hematology Department, Instituto Português Oncologia de Coimbra Francisco Gentil, Coimbra, Portugal
19Serviço de Hematologia, Hospital do Divino Espírito Santo de Ponta Delgada, Ponta Delgada, Portugal
20Serviço de Imuno-Hemoterapia, Hospital Professor Doutor Fernando Fonseca, Unidade Local de Saúde de Amadora/Sintra, Amadora, Portugal
21Hematologia Clínica, Clínica de Oncologia e Radioterapia, [formerly at] Centro Clínico SAMS, Lisboa, Portugal
22Clinical Hematology Unit, Hospital de São João, Unidade Local de Saúde São João, Porto, Portugal
23Clinical Hematology, Faculty of Medicine, University of Porto, Porto, Portugal
24i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal
25Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
26Myeloma Lymphoma Research Group, Champalimaud Foundation, Lisboa, Portugal
27NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal

Remy Lee, MD1*, Shahram Arsang-Jang, PhD1*, Anita D'Souza, MD1, Binod Dhakal, MBBS1, Siegfried Janz, MD, DSc2 and Jing Dong, PhD3

1Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI

Cindy Varga, MD, BSc1, Ferdous Ahmed, PhD2*, Marvin Knight3*, Manisha Bhutani, MD4, Barry Paul, MD, MS5, Shebli Atrash, MD, MS5, Peter M. Voorhees, MD6 and Christopher Ferreri5

1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
2levine cancer institute, Charlotte
3Atrium Health Carolina Medical Center, Charlotte
4Atrium Health Levin Cancer Institute, Charlotte, NC
5Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
6Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC

Rahul Banerjee, MD, FACP1, Ken Hasegawa, PhD2*, Taha Itani, PhD, MPH, MBA2*, Monique Giordana, PharmD, BCOP2*, Enrique Granados, MD2*, Margrit B Rosado, PharmD3*, Rebecca J Chan, MD, PhD3*, Ana Kostic, MD3*, Steve Kanters, PhD4*, Michael J Zoratti, PhD4* and Xavier Leleu5

1Fred Hutchinson Cancer Center, Seattle, WA
2Kite, A Gilead Company, Santa Monica, CA
3Arcellx, Inc., Redwood City, CA
4RainCity Analytics, Vancouver, BC, Canada
5Centre Hospitalier Universitaire de Poitiers, Poitiers, France

Adam Sciambi, PhD1*, Daniel Mendoza, PhD1*, Indira Krishnan, PhD1*, Joanne Nguyen1*, Lubna Nousheen, M.S.2*, Benjamin Geller, MSc3*, Cedric Dos Santos, PhD4, Vivek S. Chopra4*, Habib Hamidi, MPH, PhD4*, Michael Nixon5*, Yann Nouet, PhD MSc6, Todd E. Druley, MD, PhD7 and Herve Avet-Loiseau, MD, PhD8*

1Mission Bio, South San Francisco, CA
2Mission Bio, SOUTH SAN FRANCISCO, CA
3R&D, Mission Bio, South San Francisco, CA
4Genentech, Inc., South San Francisco, CA
5Roche, Indianapolis, IN
6F. Hoffmann-La Roche Ltd, Basel, Switzerland
7Mission Bio, Saint Louis, MO
8Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France

Firas Baidoun, MD1*, Ricardo D. Parrondo, MD1, Vivek Roy, MD1, Andre Fernandez, P.A. -C1*, Caitlin Flott1*, Taimur Sher, MD2*, Rami Manochakian, MD1*, Asher A. Chanan-Khan, MD1 and Sikander Ailawadhi, MD1

1Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
2Division of Hematology, Mayo Clinic, Jacksonville, FL

Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc1*, Maria Douka2*, Vassilis Koutoulidis2*, Maria Gavriatopoulou1*, Panagiotis Malandrakis, MD1*, Vasiliki Spiliopoulou, MD1*, Foteini Theodorakakou, MD1*, Despina Fotiou, MD1*, Magdalini Migkou, MD1*, Evangelos Eleutherakis-Papaiakovou, MD1*, Irene Solia, MD1*, Nikolaos Kanellias1*, Efstathios Kastritis, MD1*, Meletios Dimopoulos, MD1, Evangelos Terpos, MD, PhD1 and Lia-Angela Moulopoulos2*

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
21st Department of Radiology, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece

Claudio Cerchione, MD1, Alice Rossi, M.D.2*, Paola Caroli, M.D.3*, Matteo Marchesini, PhD1*, Federica Matteucci4*, Delia Cangini, M.D.1*, Domenico Barone4*, Davide Nappi, M.D.1*, Davide Bezzi3*, Anna Sarnelli, PhD3*, Giovanni Martinelli, M.D.5, Nicola Normanno, M.D.1* and Giacomo Feliciani, Ph.D.1*

1IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy
2IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola (FC), Italy
3IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori dino Amadori IRST, Meldola, Meldola, Italy
4Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola (FC), Italy
5Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy

Nishanth Thalambedu, MD1, Jeffery Sawyer, PhD2*, Janet L Lukacs3*, Phil Farmer4*, Samer Al-Hadidi, MD5*, Carolina Schinke, MD6, Sharmilan Thanendrarajan, MD5, Frits van Rhee, MD, PhD6 and Maurizio Zangari, MD6

1UAMS, Little Rock, AR
2University of Arkansas For Medical Sciences, Little Rock, AR
3UAMS, Littlerock, AR
4Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
5University of Arkansas for Medical Sciences, Little Rock, AR
6Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Tongyong Yu, MD1* and Juan Li, PhD2

1The first affilated hospital of sun yat-sen university, Guangzhou, AL, CHN
2The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Abiola Bolarinwa, MBBS, FMCPath1*, Madhu Nagaraj, MD1*, Saurabh Zanwar, MD, MBBS1, Nadine Abdallah, MD2, P. Leif Bergsagel, MD3, Moritz Binder, MD1, Francis Buadi, MD1, Saurabh Chhabra, MD4, Joselle Cook, MBBS1, David Dingli, MD, PhD1, Angela Dispenzieri, MD1, Morie A. Gertz, MD1, Wilson I. Gonsalves, MD5, Suzanne R Hayman, MD1, Prashant Kapoor, MD2, Taxiarchis Kourelis, MD1, Nelson Leung, MD1, Yi Lin, MD, PhD1, Eli Muchtar, MD1, Ricardo D. Parrondo, MD6, Vivek Roy, MD6, Taimur Sher, MD7*, Mustaqeem A. Siddiqui, MD, MBA1, Rahma M Warsame, MD1, Amie Fonder, PA-C, MS1*, Miriam Hobbs, APRN, CNP, DNP1*, Yi Lisa Hwa, APRN, DNP, CNP1, Michelle G. Rogers, CNP1*, Udit Yadav, MBBS8*, J E Wiedmeier-Nutor, MD, MPH8, Dragan Jevremovic, M.D., Ph.D9*, Linda B. Baughn, PhD10, Vincent Rajkumar, MD1*, Rafael Fonseca, MD3, Sikander Ailawadhi, MD6 and Shaji Kumar, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
4Division of Hematology, Mayo Clinic, Phoenix, AZ
5Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
6Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
7Division of Hematology, Mayo Clinic, Jacksonville, FL
8Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
9Division of Hematopathology, Mayo Clinic, Rochester, MN
10Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Yan Cheng1*, Fumou Sun, PhD1*, Daisy V. Alapat, MD2, Visanu Wanchai, PhD3*, David E. Mery, PhD1, Eric Siegel4*, Hongwei Xu, DDS1*, Sarah K. Johnson, PhD1*, Wancheng Guo, MD1*, Clyde Bailey, BS1*, Cody Ashby, PhD3*, Michael Anton Bauer3*, Samer Al Hadidi, MD, MSc5, Carolina Schinke, MD1, Sharmilan Thanendrarajan, MD1, Maurizio Zangari, MD1, Frits van Rhee, MD, PhD1, Guido Tricot, MD1*, John D Shaughnessy, Jr, PhD1* and Fenghuang Zhan, MD1

1Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
2Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
3Department of Bioinformatics, University of Arkansas for Medical Sciences, Little Rock, AR
4Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
5University of Arkansas for Medical Sciences, Little Rock, AR

*signifies non-member of ASH